Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000032109
Abstract: Rationale: Renal clear cell sarcoma is a rare and highly invasive malignant renal tumor that easily relapses after treatment. Recurrent recurrent clear cell carcinoma (CCSK) responds poorly to chemotherapy and has no established standardized treatment,… read more here.
Keywords: cell; anlotinib combined; cell sarcoma; recurrent clear ... See more keywords